In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Meiji Holdings Co. Ltd.

www.meiji.com

Latest From Meiji Holdings Co. Ltd.

Stock Scan February 2018: Wet But Above Water

The market slump at the beginning of February affected virtually all of the stocks of the top 50 pharmaceutical companies. But unpredicted clinical successes or surprisingly good financials still kept a few companies above water.

Device/Diagnostics Quarterly Deal Statistics, Q3 2015

$1.4 billion in Q3 device financing was slightly lower than Q2's $1.8 billion with just one IPO versus Q2's seven. Acquisitions reached a high of $23 billion and diagnostics financing increased 30% over Q2 to $1 billion, while M&A activity at $1.2 billion showed a sharp decline from the previous quarter's $15.6 billion.

Medical Device Deals

Point-Of-Care Testing Stirs Anew

Point-of-care diagnostics are back in favor with investors who believe market forces and technological advances are finally converging in ways that invite success and this time, they may be right. Profiles of GeneWEAVE, HiberGene, Spectromics, and Xagenic.

Medical Device

Asia On The Move: Takeda Hires Bayer Executive As Global Manufacturing Officer

Takeda names its first global manufacturing officer, while Daiichi Sankyo’s president leaves after the sale of Ranbaxy to India’s Sun Pharmaceuticals. Executive changes also happened at Otsuka, Meiji Seika, Chugai, and there are new general counsels at AstraZeneca and Agilent in China.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Diversified
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Meiji Holdings Co. Ltd.
  • Senior Management
  • Masahiko Matsuo, Pres.
  • Contact Info
  • Meiji Holdings Co. Ltd.
    Phone: 332734001
    2-4-16 Kyobashi, Chuo-ku
    Tokyo, 104-0031
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register